NCT07217938View on ClinicalTrials.gov

Novel Treatment of Radiation Associated Dysphagia With Statins

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2028

Conditions
Radiation-associated DysphagiaHead &Amp; Neck Cancer
Interventions
DRUG

Pravastatin 40 Mg Oral Tablet

This trial will incorporate Pravastatin 40 mg as an off-label use for the treatment of radiation-associated dysphagia.

All Listed Sponsors
lead

Peter MacCallum Cancer Centre, Australia

OTHER

NCT07217938 - Novel Treatment of Radiation Associated Dysphagia With Statins | Biotech Hunter | Biotech Hunter